ASCENSION PROVIDENCE HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.5M
- Transactions
- 984
- Companies
- 40
- Average per transaction
- $4,606
Who reported the payments
| Abbott | $1,224,872 |
| Medtronic | $1,173,831 |
| Janssen Research & Development, LLC | $352,738 |
| Bristol Myers Squibb | $291,152 |
| Merck | $245,660 |
| Medical Device Business Services, Inc. | $129,096 |
| Inari Medical, Inc. | $125,636 |
| Impulse Dynamics (USA) Inc. | $113,560 |
| Stryker | $103,185 |
| Cochlear Americas | $65,298 |
| Shockwave Medical, Inc | $63,979 |
| Novartis | $62,597 |
| Amgen | $55,885 |
| E.r. Squibb & Sons, L.L.C. | $53,349 |
| Cvrx, Inc. | $43,095 |
| Tandem Diabetes Care, Inc. | $40,825 |
| Ethicon Endo-surgery Inc. | $29,294 |
| Edwards Lifesciences | $28,500 |
| AbbVie | $26,686 |
| Pfizer | $22,740 |
| Johnson & Johnson | $18,700 |
| AstraZeneca | $18,165 |
| Emergent Biosolutions Inc. | $15,774 |
| Morphosys AG | $15,500 |
| Janssen Scientific Affairs, LLC | $15,300 |
| Chiesi USA, Inc. | $15,300 |
| Olympus America Inc. | $15,232 |
| Boehringer Ingelheim | $15,000 |
| Boston Scientific | $13,403 |
| Insulet Corporation | $12,125 |
| Takeda Pharmaceuticals U.S.A., Inc. | $10,464 |
| Alnylam Pharmaceuticals Inc. | $10,000 |
| Zimmer Biomet | $9,953 |
| Varian Medical Systems, Inc. | $8,806 |
| Otonomy, Inc. | $8,700 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $7,167 |
| Eisai Inc. | $5,500 |
| ZOLL Medical Corporation | $5,001 |
| ZOLL Circulation Inc | $5,000 |
| Bard Peripheral Vascular, Inc. | $4,002 |